Literature DB >> 8098403

Misoprostol and illegal abortion in Fortaleza, Brazil.

H L Coêlho1, A C Teixeira, A P Santos, E B Forte, S M Morais, C La Vecchia, G Tognoni, A Herxheimer.   

Abstract

Misoprostol, a prostaglandin E1 analogue indicated for ulcer treatment, has been widely used as an abortifacient by women in Brazil, where abortion is legal only in cases of rape or incest, or to save the woman's life. Because misoprostol is an inefficient abortifacient, many women who use it have incomplete abortions and need uterine evacuation. We reviewed the records of women admitted to the main obstetric hospital of Fortaleza, capital of Ceará state, Brazil, between January, 1990, and July, 1992, for uterine evacuation after induced abortion. The number of incomplete abortions induced by misoprostol increased substantially during the first half of 1990, and declined thereafter. Of the 593 cases in 1991, 75% were related to misoprostol, 10% to the use of other specified drugs, and 6% to unspecified drugs. For the remaining 9% the procedure used was not recorded; these included 3% in whom abortion had been induced by a clandestine abortionist. The number of uterine evacuations per month fell from 89 in August, 1990, to 62 in July, 1991, when sales of misoprostol in Ceará state were suspended. The fall continued after the sale of misoprostol ceased, to about 20 cases in December, 1991; numbers remained around this level until June, 1992, sustained by clandestine sales. The lack of access to contraception is the main reason for the large numbers of unplanned pregnancies and is a major public health issue for Brazilian women. The prohibition of abortion creates a void in which misuse of medicines is one extra complication, mainly because of the poor control of drug marketing.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Substances:

Year:  1993        PMID: 8098403     DOI: 10.1016/0140-6736(93)91157-h

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Political, economic and ethical aspects of use of medical abortifacients.

Authors:  P J Macrow
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

2.  Misoprostol and attempted self-induction of abortion.

Authors:  M M Jones; K Fraser
Journal:  J R Soc Med       Date:  1998-04       Impact factor: 5.344

3.  Autism with ophthalmologic malformations: the plot thickens.

Authors:  Marilyn T Miller; Kerstin Strömland; Liana Ventura; Maria Johansson; Jose M Bandim; Christopher Gillberg
Journal:  Trans Am Ophthalmol Soc       Date:  2004

4.  The etiology of möbius syndrome: a social problem?

Authors:  Geraldo Pereira Jotz; Karine Schwarz
Journal:  Int Arch Otorhinolaryngol       Date:  2014-07

5.  The magnitude and severity of abortion-related morbidity in settings with limited access to abortion services: a systematic review and meta-regression.

Authors:  Clara Calvert; Onikepe O Owolabi; Felicia Yeung; Rudiger Pittrof; Bela Ganatra; Özge Tunçalp; Alma J Adler; Veronique Filippi
Journal:  BMJ Glob Health       Date:  2018-06-29

Review 6.  Latin American women's experiences with medical abortion in settings where abortion is legally restricted.

Authors:  Nina Zamberlin; Mariana Romero; Silvina Ramos
Journal:  Reprod Health       Date:  2012-12-22       Impact factor: 3.223

Review 7.  The mesoeconomics of abortion: A scoping review and analysis of the economic effects of abortion on health systems.

Authors:  Samantha R Lattof; Ernestina Coast; Yana van der Meulen Rodgers; Brittany Moore; Cheri Poss
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

8.  Misoprostol in the era of COVID-19: a love letter to the original medical abortion pill.

Authors:  Ruvani T Jayaweera; Heidi Moseson; Caitlin Gerdts
Journal:  Sex Reprod Health Matters       Date:  2020-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.